A Mom Didn’t Feel Taken Seriously—Rare Disease Diagnosis Follows
A mom didn t feel taken – A mom didn’t feel taken seriously as her symptoms worsened, leading to a life-altering diagnosis. Michelle Williams, a devoted parent during the pandemic, found herself overwhelmed by the demands of caring for two young children and renovating her new farmhouse. When she began experiencing elevated blood pressure, she initially blamed stress and followed her doctor’s advice to make minor adjustments. However, as her condition progressed, her symptoms became more severe: swollen feet requiring larger shoes, persistent fatigue, and frequent nighttime trips to the bathroom. Despite these red flags, her concerns were dismissed, and it wasn’t until a referral to a kidney specialist in June 2023 that her health took a more serious turn.
Williams described her first visit to the specialist as frustrating. The physician assistant she met showed little interest in her printed medical records or the growing list of symptoms she had been tracking. She was told to focus on lifestyle changes and asked to wait six months for further evaluation. “I didn’t feel like I had six months to wait,” she recalled, highlighting her growing anxiety. The delay in diagnosis left her feeling powerless, as her body continued to betray her with worsening signs that she knew were more than just stress-related.
“I didn’t really feel like I had six months to wait.”
Her determination to seek answers eventually led her to the Cleveland Clinic, where her father-in-law had previously received a kidney transplant. There, she submitted her medical history and wrote a heartfelt letter to the team, pleading for more thorough attention. After several weeks of consultations, she was scheduled for two full days of testing. The process revealed alarming results, prompting a call from the nephrologist who had initially dismissed her case. The diagnosis of multiple myeloma—a blood cancer linked to kidney complications—shocked her and her husband, who now faced an uncertain path forward.
Williams underwent bone marrow and kidney biopsies within 24 hours. The findings confirmed her fears: her urine and blood samples showed abnormalities consistent with IC-MPGN, a rare kidney disease connected to immune system dysfunction. While her initial treatment included steroids and immunosuppressants, these therapies provided only temporary relief. “If we are addressing the root cause and she’s not improving, then what else are we missing?” Dr. Jagmeet Dhingra, a Cleveland Clinic nephrologist, asked, reflecting on the frustration of a condition that was both misunderstood and under-treated.
Understanding IC-MPGN
IC-MPGN, or immune complex-mediated proliferative glomerulonephritis, is a rare kidney disorder that often goes undiagnosed for months or even years. Dr. Carla Nester, a nephrologist and researcher at the University of Iowa, described it as one of the rarest kidney diseases, with only one to four cases identified per million people annually. Unlike more common kidney conditions, IC-MPGN typically presents with nonspecific symptoms like swelling and fatigue, which Williams recognized from her own experience. These early signs are often dismissed as stress or aging, delaying critical treatment and worsening the patient’s condition.
At the time of her diagnosis, IC-MPGN had limited targeted therapies. Patients were usually treated with steroids, immunosuppressants, and chemotherapy, which could alleviate symptoms but rarely halt disease progression. Doctors often warned that without intervention, the condition could lead to end-stage kidney disease within a decade, even with a transplant. For Williams, this prognosis was a sobering realization that her symptoms had not been random but the result of a complex and rare disease she had yet to understand.
Hope from a Clinical Trial
The discovery of IC-MPGN opened new possibilities for Williams. While traditional treatments offered only temporary relief, a clinical trial at the Cleveland Clinic presented a breakthrough. The trial focused on advanced therapies designed to address the underlying immune system dysfunction, offering hope that her condition could be managed more effectively. “This gives me something to hold onto,” she said, describing the renewed sense of purpose that came with the trial. The opportunity to test new treatments meant she could potentially avoid the long-term complications that had been looming over her for months.
Williams’s journey highlights the importance of early diagnosis in rare diseases. Her persistence in seeking answers, despite initial dismissals, ultimately led to a precise identification of her condition. The Cleveland Clinic’s expertise in kidney transplants and immunology played a crucial role in her treatment, emphasizing the value of specialized care. For other moms who may feel overlooked, her story serves as a reminder that persistence can lead to life-changing discoveries, even when symptoms are dismissed as routine.
